R2*与表观扩散系数在评估膀胱癌肿瘤分级和T分期中的应用
这项前瞻性研究纳入58例经病理确诊的膀胱癌患者,于3-T MRI上行T2*加权成像和DWI,计算R2*和ADC。低级别与高级别膀胱癌间R2*和ADC均有显著差异,肌层浸润性膀胱癌(MIBC)较非肌层浸润性膀胱癌(NMIBC)R2*更高、ADC更低;ADC鉴别NMIBC与MIBC的AUC为0.850,R2*为0.682。作者认为R2*可作为定量影像生物标志物,为膀胱癌肿瘤表征提供补充信息。
要点
- ADC鉴别NMIBC与MIBC的AUC为0.850,高于R2*的0.682。
- 低级别与高级别膀胱癌间R2*和ADC均存在显著差异。
- MIBC较NMIBC的R2*更高(22.56 ± 8.41 vs 18.06 ± 6.46 s-1),ADC更低(1.21 ± 0.18 vs 1.53 ± 0.27 × 10-3 mm2/s)。
诊断标准与关键数值
- 低级别与高级别膀胱癌:R2*均值16.55 ± 5.54 vs 20.96 ± 7.75 s-1(p=0.001),ADC均值1.62 ± 0.31 vs 1.33 ± 0.21 × 10-3 mm2/s(p<0.001)。
- NMIBC与MIBC:R2*均值18.06 ± 6.46 vs 22.56 ± 8.41 s-1(p=0.008),ADC均值1.53 ± 0.27 vs 1.21 ± 0.18 × 10-3 mm2/s(p<0.001)。
- 鉴别低级别与高级别膀胱癌的AUC:R2*为0.714,ADC为0.779。
- 鉴别NMIBC与MIBC的AUC:R2*为0.682,ADC为0.850。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to compare the feasibility of R2* and apparent diffusion coefficient (ADC) for differentiating tumor grade and T category of bladder cancer. SUBJECTS AND METHODS. In this prospective study, 58 patients with pathologically confirmed bladder cancers underwent pretreatment T2*-weighted imaging and DWI on a 3-T MRI unit. The apparent transverse relaxation rate R2*, which is derived from T2*-weighted imaging, and ADC, which is derived from DWI, were calculated and compared between low- and high-grade bladder cancers as well as between non-muscle-invasive bladder cancers (NMIBCs) and muscle-invasive bladder cancers (MIBCs) using the Mann-Whitney U test. The diagnostic performances of R2*, ADC, and the combination of R2* and ADC were evaluated through an ROC analysis. RESULTS. Significant differences were found in R2* (mean ± SD, 16.55 ± 5.54 vs 20.96 ± 7.75 s-1; p = 0.001) and ADC (1.62 ± 0.31 vs 1.33 ± 0.21 × 10-3 mm2/s; p < 0.001) between lowand high-grade bladder cancers. R2* was significantly higher (22.56 ± 8.41 vs 18.06 ± 6.46 s-1; p = 0.008) and ADC was considerably lower (1.21 ± 0.18 vs 1.53 ± 0.27 × 10-3 mm2/s; p < 0.001) in MIBCs than in NMIBCs. The AUCs for differentiating low-from high-grade groups were 0.714 using R2* and 0.779 using ADC. AUCs for distinguishing between NMIBC and MIBC groups using R2* and ADC were 0.682 and 0.850, respectively. CONCLUSION. In addition to ADC, R2* can be used as a quantitative imaging biomarker to provide additional information for tumor characterization of bladder cancer.
引用
- Wang Y, Shen Y, Hu X, et al. Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer. AJR Am J Roentgenol. 2019. PMID: 31670586. doi:10.2214/AJR.19.21668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。